Clobetasol propionate
Clobederm cream is a medicine for use on the skin, containing the active substance clobetasol propionate. Clobetasol propionate is a very potent synthetic glucocorticosteroid (a type of hormone) for local use on the skin. The medicine has very potent anti-inflammatory, anti-itching, anti-allergic, and vasoconstrictive effects.
Clobederm cream is used locally for the short-term treatment of acute and severe, non-infected, weeping skin conditions that respond to glucocorticosteroids and are accompanied by persistent itching or excessive scaling, when treatment with weaker glucocorticosteroid preparations has failed. Clobederm is indicated for: seborrheic dermatitis, contact dermatitis, atopic dermatitis, chronic psoriasis, discoid lupus erythematosus, polymorphic light eruption, and prurigo nodularis.
Before starting to use Clobederm cream, discuss with your doctor or pharmacist or nurse if:
If you experience irritation or skin allergic reaction after using Clobederm cream, inform your doctor immediately. The doctor will decide whether to discontinue the use of the medicine. If you experience blurred vision or other vision disturbances, contact your doctor. Do not use the medicine continuously for more than 2 weeks. Due to the fact that corticosteroids are absorbed through the skin, during prolonged use of the medicine or use on a large skin surface, the frequency of general side effects characteristic of corticosteroids increases, such as edema, hypertension, increased blood sugar levels, and decreased immunity. Therefore, you should avoid using the medicine on a large body surface. If an infection occurs at the site of application, the doctor will apply appropriate antibacterial or antifungal treatment. If the symptoms of infection do not resolve, contact your doctor. The doctor will decide whether to discontinue the use of the medicine until the infection is cured. Avoid contact of the medicine with eyes, mucous membranes, or wounds. Avoid using the medicine around the eyes due to the risk of glaucoma or cataracts. Avoid using the medicine on the eyelids or on the skin around the eyelids, especially in people with glaucoma with narrow or wide angle of filtration and in people with cataracts, due to the risk of exacerbating the disease symptoms. Patients with psoriasis should use the medicine with special caution, as local use of corticosteroids in psoriasis can be dangerous for several reasons, including the risk of disease relapse due to the development of tolerance, the risk of generalized pustular psoriasis, and general toxic effects due to skin barrier disruption. On the face and in the axillary and groin areas, use only in cases where it is absolutely necessary, due to increased absorption of corticosteroids through delicate skin and a higher risk of side effects, such as telangiectasia or perioral dermatitis, even after short-term use. Use with caution in existing atrophic conditions of subcutaneous tissue, especially in the elderly. Do not use the medicine for longer than prescribed by your doctor.
Do not use in children under 12 years of age. Use with caution in children over 12 years of age. In children, due to the higher ratio of body surface area to body mass compared to adults, there is a higher risk of systemic side effects of corticosteroids, such as disruption of the hypothalamic-pituitary-adrenal axis and Cushing's syndrome (a syndrome of disease symptoms associated with increased steroid levels in the blood, most commonly caused by prolonged administration of glucocorticosteroids). Chronic treatment with corticosteroids may disrupt growth and development in children.
Tell your doctor or pharmacist about all medicines you are taking or have recently taken, as well as any medicines you plan to take. There are no known interactions during local use of corticosteroids with other medicines. Do not get vaccinated against smallpox while using the medicine. Do not get other vaccinations, especially during prolonged use of the medicine or use on a large skin surface. The medicine may enhance the effects of medicines that affect the immune system.
If you are pregnant or breast-feeding, think you may be pregnant, or are planning to have a baby, ask your doctor or pharmacist for advice before using this medicine. Women who are pregnant or breast-feeding should not use the medicine unless it is absolutely necessary, as it contains a very potent glucocorticosteroid.
Clobederm cream has no influence on the ability to drive and use machines.
Always use this medicine exactly as your doctor or pharmacist has told you. If you are not sure, ask your doctor or pharmacist. Do not use the medicine for longer than prescribed by your doctor. The medicine is for use on the skin only. Gently rub a small amount of cream into the affected areas of skin, usually once or twice a day. Do not use the medicine under occlusive dressing (tight bandage), diaper, or bandage. After using the medicine, wash your hands. Treatment should not be continued without interruption for more than 2 weeks. After improvement, treatment should be discontinued. If further treatment with corticosteroids is necessary, the doctor will use medicines containing corticosteroids with lower potency, ensuring control of disease symptoms.
Do not use in children under 12 years of age.
After prolonged use or use on large skin surfaces, symptoms of overdose may occur, such as edema, hypertension, increased blood sugar levels, decreased immunity, and Cushing's syndrome. If you experience symptoms of overdose, contact your doctor.
Do not use a double dose to make up for a forgotten dose.
If you have any further questions about using this medicine, ask your doctor.
Like all medicines, this medicine can cause side effects, although not everybody gets them. The following side effects have a frequency not known (frequency cannot be estimated from the available data): Changes similar to acne, perioral dermatitis, skin atrophy, burning sensation, itching, irritation, rash, subcutaneous tissue atrophy, skin dryness, excessive hair growth or hair loss, skin discoloration or hyperpigmentation, skin atrophy and striae, telangiectasia, perioral dermatitis, folliculitis, secondary infections, generalized pustular psoriasis. Sometimes, urticaria or papular-pustular rash may occur, or worsening of existing disease symptoms, as well as blurred vision. When used locally on the eyelids, glaucoma or cataracts may occur. Due to the absorption of the active substance into the blood, systemic side effects of clobetasol propionate may also occur. These occur mainly in the case of prolonged use of the medicine, use on a large skin surface, under occlusive dressing, or in children.
In children, systemic side effects of clobetasol propionate may occur. Systemic side effects of clobetasol propionate characteristic of corticosteroids include: suppression of the hypothalamic-pituitary-adrenal axis, Cushing's syndrome, growth and development inhibition in children, increased blood sugar levels, glycosuria, edema, hypertension, and decreased immunity.
If you experience any side effects, including any not listed in this leaflet, please tell your doctor, pharmacist, or nurse. Side effects can be reported directly to the Department of Pharmacovigilance of the Office for Registration of Medicinal Products, Medical Devices, and Biocidal Products, Al. Jerozolimskie 181C, 02-222 Warsaw, tel.: +48 22 49 21 301, fax: +48 22 49 21 309, website: https://smz.ezdrowie.gov.pl. Side effects can also be reported to the marketing authorization holder. By reporting side effects, you can help provide more information on the safety of this medicine.
Keep this medicine out of the sight and reach of children. Store in a temperature below 25°C. Do not freeze. Do not use this medicine after the expiry date stated on the packaging. The expiry date refers to the last day of the month stated. Shelf life after first opening the tube: 3 months. Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. This will help protect the environment.
Clobederm cream is a white, homogeneous cream with a characteristic odor. The pack contains a 25g aluminum tube, placed in a cardboard box.
Bausch Health Ireland Limited, 3013 Lake Drive, Citywest Business Campus, Dublin 24, D24PPT3, Ireland
Przedsiębiorstwo Farmaceutyczne Jelfa SA, ul. Wincentego Pola 21, 58-500 Jelenia Góra, tel. (075) 643 31 02, fax. (075) 752 44 55, e-mail: jelfa@jelfa.com.pl, Date of last revision of the leaflet:
Need help understanding this medicine or your symptoms? Online doctors can answer your questions and offer guidance.